KNTK vs REGN · P/E 18, rev $991.4M vs P/E 14, rev $4.29B
Kinetik Holdings Inc (KNTK) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Kinetik Holdings Inc (KNTK) is a oil & gas midstream company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported KNTK revenue for 2026-06-30 was $991.4M. Net income was $47.9M. KNTK currently screens at market cap $7.55B and trailing P/E 18.0.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
KNTK currently screens at market cap $7.55B and trailing P/E 18.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the KNTK and REGN stock pages for the full models.
Not investment advice.